Tweet
SAGE Open Med Case Rep
. 2023 Dec 4:11:2050313X231212985.
doi: 10.1177/2050313X231212985. eCollection 2023. Treatment of coronavirus disease 2019-associated mucositis in adolescents: A case report and brief literature review
Mina Boshra 1 , Feras M Ghazawi 1 , Carmen Liy-Wong 2
Affiliations
Reactive Infectious Mucocutaneous Eruption is an acute mucocutaneous inflammation secondary to an infection with minimal to absent cutaneous features that has recently been linked to the Severe Acute Respiratory Syndrome Coronavirus-19 (SARS-CoV-19 virus). Unfortunately, the relative rarity of case reports of Reactive Infectious Mucocutaneous Eruption in paediatric populations has led to fewer known successful treatment options with the current mainstay being systemic immunosuppression (e.g. corticosteroids, cyclosporine and etanercept). In this case report, we discuss a case of an adolescent patient with (polymerase chain reaction) PCR+ coronavirus disease 2019 infection and an oral eruption without cutaneous symptoms. He was treated successfully using a single dose of dexamethasone and supportive care through amorphous hydrogel (Intrasite gel), thus providing a safe, cheap and effective treatment option in mild coronavirus disease 2019-associated Reactive Infectious Mucocutaneous Eruption in paediatric patients. We also discuss the current findings, diagnostic terms and treatment options of mucosal manifestations of coronavirus disease 2019 in children.
Keywords: COVID-19; intrasite gel; mucositis; paediatric; teenager.
. 2023 Dec 4:11:2050313X231212985.
doi: 10.1177/2050313X231212985. eCollection 2023. Treatment of coronavirus disease 2019-associated mucositis in adolescents: A case report and brief literature review
Mina Boshra 1 , Feras M Ghazawi 1 , Carmen Liy-Wong 2
Affiliations
- PMID: 38059177
- PMCID: PMC10697032
- DOI: 10.1177/2050313X231212985
Reactive Infectious Mucocutaneous Eruption is an acute mucocutaneous inflammation secondary to an infection with minimal to absent cutaneous features that has recently been linked to the Severe Acute Respiratory Syndrome Coronavirus-19 (SARS-CoV-19 virus). Unfortunately, the relative rarity of case reports of Reactive Infectious Mucocutaneous Eruption in paediatric populations has led to fewer known successful treatment options with the current mainstay being systemic immunosuppression (e.g. corticosteroids, cyclosporine and etanercept). In this case report, we discuss a case of an adolescent patient with (polymerase chain reaction) PCR+ coronavirus disease 2019 infection and an oral eruption without cutaneous symptoms. He was treated successfully using a single dose of dexamethasone and supportive care through amorphous hydrogel (Intrasite gel), thus providing a safe, cheap and effective treatment option in mild coronavirus disease 2019-associated Reactive Infectious Mucocutaneous Eruption in paediatric patients. We also discuss the current findings, diagnostic terms and treatment options of mucosal manifestations of coronavirus disease 2019 in children.
Keywords: COVID-19; intrasite gel; mucositis; paediatric; teenager.